RVLPQ OTC
RVL Pharmaceuticals plc
1W: +900.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$129M
-11.2% ▼
5Y CAGR: -32.5%
Total Liabilities
$77M
+14.0% ▲
5Y CAGR: -30.7%
Shareholders Equity
$51M
-33.4% ▼
5Y CAGR: -34.9%
Cash & Investments
$45M
+2.4% ▲
5Y CAGR: +5.1%
Total Debt
$57M
+20.7% ▲
5Y CAGR: -29.1%
Net Debt
$13M
+79.8% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $71M | $96M | $114M | $40M | $45M |
| Short-Term Investments | $0 | $0 | $0 | $3M | $0 |
| Cash & ST Investments | $71M | $96M | $114M | $44M | $45M |
| Net Receivables | $56M | $44M | $3M | $2M | $3M |
| Inventory | $24M | $21M | $2M | $838K | $784K |
| Other Current Assets | $0 | $0 | $42M | $0 | $9M |
| Total Current Assets | $172M | $173M | $173M | $59M | $57M |
| Property, Plant & Equip. | $31M | $35M | $4M | $2M | $2M |
| Goodwill & Intangibles | $101M | $255M | $91M | $83M | $70M |
| Long-Term Investments | $490M | -$7M | -$13M | $0 | $0 |
| Other Non-Current Assets | $752K | $563K | $103M | -$11M | $0 |
| Total Non-Current Assets | $655M | $291M | $198M | $85M | $72M |
| Total Assets | $827M | $463M | $371M | $145M | $129M |
| — Liabilities — | |||||
| Accounts Payable | $25M | $8M | $3M | $4M | $2M |
| Short-Term Debt | $2M | $0 | $1M | $2M | $1M |
| Deferred Revenue | $101K | $0 | $17M | $67K | $2M |
| Other Current Liabilities | $78M | $54M | $23M | $9M | $10M |
| Total Current Liabilities | $114M | $76M | $56M | $20M | $20M |
| Long-Term Debt | $267M | $268M | $220M | $44M | $56M |
| Other Non-Current Liab. | $3M | $0 | $568K | $3M | $2M |
| Total Non-Current Liabilities | $329M | $273M | $221M | $48M | $58M |
| Total Liabilities | $443M | $349M | $277M | $68M | $77M |
| — Equity — | |||||
| Common Stock | $525K | $518K | $625K | $833K | $992K |
| Retained Earnings | -$102M | -$373M | -$453M | -$518M | -$569M |
| Accumulated OCI | -$2M | -$2M | -$2M | $2M | $0 |
| Total Stockholders Equity | $384M | $115M | $94M | $77M | $51M |
| Total Liabilities & Equity | $827M | $463M | $371M | $145M | $129M |
| — Key Metrics — | |||||
| Total Debt | $269M | $273M | $222M | $48M | $57M |
| Net Debt | $198M | $177M | $108M | $7M | $13M |
| Total Investments | $490M | -$7M | -$13M | $3M | $0 |